Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$5.9MFederal grants as PI11 awards
5Patents grantedLatest Dec 17, 2024
87Papers1,667 citations
Federal awards and patents by year
AwardsPatents
11 awards · $5.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 4, 2026 | NIH | SBIR Phase I New TREM-1 therapy for inflammatory bowel disease | $353K | SIGNABLOK, INC. |
| May 13, 2026 | NIH | SBIR Phase II First-in-class TREM-1 inhibitors for neovascular retinal diseases | $830K | SIGNABLOK, INC. |
| Sep 10, 2025 | NIH | SBIR Phase I TREM-1 therapy for the treatment of empyema | $458K | SIGNABLOK, INC. |
| Apr 7, 2025 | NIH | SBIR Phase II First-in-class TREM-1 inhibitors for neovascular retinal diseases | $830K | SIGNABLOK, INC. |
| Sep 6, 2023 | NIH | SBIR Phase II First-in-class TREM-1 inhibitors for neovascular retinal diseases | $278K | SIGNABLOK, INC. |
| Jul 31, 2023 | NIH | SBIR Phase I New mechanism-based TREM-1 therapy for acute respiratory distress syndrome | $273K | SIGNABLOK, INC. |
| Sep 4, 2020 | NIH | SBIR Phase II First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer | $1.2M | SIGNABLOK, INC. |
| Sep 25, 2019 | NIH | SBIR Phase II First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer | $800K | SIGNABLOK, INC. |
| Aug 13, 2019 | NIH | SBIR Phase I First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer | $2K | SIGNABLOK, INC. |
| Sep 21, 2017 | NIH | SBIR Phase I First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer | $225K | SIGNABLOK, INC. |
| Jun 8, 2015 | NIH | SBIR Phase II Multifunctional nanoformulations for diagnostic imaging of atherosclerosis | $673K | SIGNABLOK, INC. |
6 patents as inventor
- US 10538558SIGNABLOK, INC.Jan 21, 2020
- US 10894098SIGNABLOK, INC.Jan 19, 2021
- US 11638739SIGNABLOK, INC.May 2, 2023
- US 12036294SIGNABLOK, INC.Jul 16, 2024
- US 12168034SIGNABLOK, INC.Dec 17, 2024
- US SIGNABLOK, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#199
Awards as PI#106
Patents#25
Companies
- SIGNABLOK, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.